-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UmIbr7fx82LgUyzYwrm5uuJk34Z23mfk5o9/I8V3QijCuKRyJUUv/Oi+LfOs53Ty WhG5MUi2R8//pkfBO1sfzQ== 0001181431-04-059485.txt : 20041217 0001181431-04-059485.hdr.sgml : 20041217 20041217100947 ACCESSION NUMBER: 0001181431-04-059485 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041209 FILED AS OF DATE: 20041217 DATE AS OF CHANGE: 20041217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIBERTY MINT LTD CENTRAL INDEX KEY: 0001042420 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 841409219 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4370 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 685 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8585462460 MAIL ADDRESS: STREET 1: 4370 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 685 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kinsella Kevin J CENTRAL INDEX KEY: 0001311643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27409 FILM NUMBER: 041210020 BUSINESS ADDRESS: BUSINESS PHONE: 858-546-2460 MAIL ADDRESS: STREET 1: 4370 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 685 CITY: SAN DIEGO STATE: CA ZIP: 92122 4 1 rrd61722.xml 4 X0202 4 2004-12-09 0 0001042420 LIBERTY MINT LTD LBML.OB 0001311643 Kinsella Kevin J 4370 LA JOLLA VILLAGE DRIVE SUITE 685 SAN DIEGO CA 92122 1 0 1 0 Common Stock 2004-12-09 4 A 0 2788577 A 2788577 D Shares received in exchange for shares of Akesis Pharmaceuticals, Inc. (a privately held corporation) common stock held by Mr. Kinsella in connection with the merger of Ann Arbor Acquisition Corporation, a wholly-owned subsidiary of Liberty Mint, Ltd., with and into Akesis Pharmaceuticals, Inc. Akesis Pharmaceuticals is the surviving corporation and stockholders of Akesis Pharmaceuticals, including Mr. Kinsella, received their pro rata share of approximately 10,500,000 shares of Liberty Mint, Ltd. common stock. On December 9, 2004, the effective date of the merger, the closing price of Liberty Mint, Ltd. common stock was $5.75 per share. /s/ Kevin J. Kinsella 2004-12-16 -----END PRIVACY-ENHANCED MESSAGE-----